Although it is has been shown that B7-H3.CAR-28ζ-Ts and B7-H3.CAR-BBζ-Ts showed equivalent antitumor properties in tumor models [17], incorporating 4-1BB signaling into the CAR molecular cellular domain could enhance CAR-T cell expansion in vivo in certain models [27]. The gene discussed is CD276; the disease is neoplasm.